Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Jie%2C+Guang-Ling%22&type=Person&sort=year
/vufind/Search/Results?lookfor=%22Jie%2C+Guang-Ling%22&type=Person&sort=year
Search /vufind/Search2/Results?lookfor=%22Jie%2C+Guang-Ling%22&type=Person&sort=year
PubPharm (12)
1
Novel systemic therapies in the management of tyrosine kinase inhibitor-pretreated patients with epidermal growth factor receptor-mutant non-small-cell lung cancer
enthalten in:
Therapeutic advances in medical oncology
| 2023
von
Li, Y.
|
Jie, G.
|
Wu, Y.
Wird geladen...
2
Prognostic features and comprehensive genomic analysis of NF1 mutations in EGFR mutant lung cancer patients
enthalten in:
Cancer medicine
| 2023
von
Tian, H.
|
Chen, Z.
|
Jie, G.
| +7
Wird geladen...
3
Longitudinal Plasma Proteomics-Derived Biomarkers Predict Response to MET Inhibitors for MET-Dysregulated NSCLC
enthalten in:
Cancers
| 2023
von
Jie, G.
|
Peng, L.
|
Zheng, M.
| +12
Wird geladen...
4
Prognostic features and comprehensive genomic analysis of NF1 mutations in EGFR mutant lung cancer patients
enthalten in:
Cancer Medicine
| 2023
von
Tian, H.
|
Chen, Z.
|
Jie, G.
| +7
Wird geladen...
5
Toward a cure for lung cancer : important advances in operable non-small cell lung cancer
enthalten in:
Science bulletin
| 2022
von
Liu, S.
|
Jie, G.
|
Wu, Y.
Wird geladen...
6
Epidermal growth factor receptor-targeted therapy for the treatment of non-small cell lung cancer : a review of phase II and III trials
enthalten in:
Expert opinion on emerging drugs
| 2022
von
Lu, H.
|
Jie, G.
|
Wu, Y.
Wird geladen...
7
Epidermal growth factor receptor-targeted therapy for the treatment of non-small cell lung cancer: a review of phase II and III trials
enthalten in:
Expert opinion on emerging drugs
| 2022
von
Lu, H.
|
Jie, G.
|
Wu, Y.
Wird geladen...
8
MET amplification identified by next-generation sequencing and its clinical relevance for MET inhibitors
enthalten in:
Experimental hematology & oncology
| 2021
von
Peng, L.
|
Jie, G.
|
Li, A.
| +13
Wird geladen...
9
MET amplification identified by next-generation sequencing and its clinical relevance for MET inhibitors
enthalten in:
Experimental hematology & oncology
| 2021
von
Peng, L.
|
Jie, G.
|
Li, A.
| +13
Wird geladen...
10
Clinical characteristics and prognostic value of the KRAS G12C mutation in Chinese non-small cell lung cancer patients
enthalten in:
Biomarker Research
| 2020
von
Liu, S.
|
Sun, H.
|
Zhou, J.
| +10
Wird geladen...
1
2
Nächster »
[2]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Medienart
12
Aufsätze
12
E-Artikel
12
E-Ressourcen
Zeitschriftentitel
2
Biomarker Research
2
Experimental hematology & oncology
2
Expert opinion on emerging drugs
1
Biomarker research
1
Cancer Medicine
1
Cancer medicine
1
Cancers
1
Science bulletin
1
Therapeutic advances in medical oncology
Alle anzeigen ...
weniger ...
Thema
7
Journal Article
4
Non-small cell lung cancer
3
Chinese patients
3
EGFR
3
Prognosis
3
targeted therapy
2
EC 2.7.10.1
2
ErbB Receptors
2
FISH-NGS
2
NSCLC
2
Predictive factors
2
Review
2
Survival benefits
2
clinical trials
2
mutation
1
EGFR protein, human
1
KRAS G12C mutation
1
KRAS mutation
1
MET amplification
1
MET dysregulation
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
4
2023
3
2022
2
2021
3
2020
Erscheinungsjahr(e)
Von:
Bis:
Sprache
11
Englisch
Haven't found what you're looking for?
Wird geladen...